New User:

Forgot your password?

Stock Market & Financial Investment News

Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
November 18, 2015
14:05 EDTORCLOracle continues to believe Cloud will become bigger part of software offering
Subscribe for More Information
11:24 EDTGOOGGoogle eyes YouTube enhancement with VR experiences, DigiTimes says
Subscribe for More Information
10:29 EDTORCLOptions with increasing implied volatility
Options with increasing implied volatility: TERP CSC SGMS RH BBRY ULTA SNDK ORCL NKE VNET
05:40 EDTRADStocks with implied volatility below IV index mean; YUM RAD
Subscribe for More Information
November 17, 2015
19:11 EDTGOOGGoogle launches redesigned Google+
Subscribe for More Information
11:25 EDTGOOGGoogle to fight Russia's antitrust ruling on Android platform, Reuters reports
Subscribe for More Information
09:27 EDTMDRXAllscripts management to meet with Leerink
Subscribe for More Information
09:03 EDTICEICE Future Europe introduces white sugar futures contract in 2016
Subscribe for More Information
06:35 EDTGOOGGoogle's Project Aura working on three new wearables, the Information says
Google's revamped Google Glass project, known as Project Aura, is developing a wearable with a screen and at least one without, the Information reports. Three versions of the head-mounted device are currently in development, though three may be consolidated into two, the report says. The two without a screen rely on bone conduction, much like the original Google Glass, the report says. Reference Link
06:26 EDTMDRXThe Advisory Board initiated with an Overweight at JPMorgan
Subscribe for More Information
November 16, 2015
10:00 EDTORCLOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Alliant Energy (LNT) upgraded to Outperform from Market Perform at Wells Fargo... AmerisourceBergen (ABC) upgraded to Equal Weight from Underweight at Morgan Stanley... Amphenol (APH) upgraded to Buy from Neutral at Goldman... CA Technologies (CA) upgraded to Neutral from Sell at Citi... Cempra (CEMP) upgraded to Overweight from Equal Weight at Morgan Stanley... Edgewell Personal Care (EPC) upgraded to Neutral from Sell at Goldman... Eli Lilly (LLY) upgraded on improved growth outlook at BMO Capital... MiMedx (MDXG) upgraded to Strong Buy from Buy at Needham... NVIDIA (NVDA) upgraded to Buy from Hold at Canaccord... New York REIT (NYRT) upgraded to Buy from Hold at Evercore ISI... Oracle (ORCL) upgraded to Conviction Buy from Buy at Goldman... Perrigo (PRGO) upgraded to Buy from Neutral at UBS... Semtech (SMTC) upgraded to Buy from Neutral at B. Riley... Tullow Oil (TUWOY) upgraded to Buy from Neutral at UBS... Wabtec (WAB) upgraded to Outperform on valuatoin at Raymond James.
09:53 EDTORCLOracle rallies, levels to watch
Subscribe for More Information
09:37 EDTORCLActive equity options trading on open
Active equity options trading on open: AAPL FB ORCL BAC SUNE FDX FCX EXPE NFLX MU AMZN INTC TSLA
09:33 EDTGOOGeBay second week of November SSS up 0.4%, ChannelAdvisor says
Subscribe for More Information
09:06 EDTRADDiplomat seen as compelling amid specialty pharmacy fallout
Shares of specialty pharmacy operator Diplomat Pharmacy (DPLO) and pharmacy benefit manager Express Scripts (ESRX) have each been knocked down by the negative news surrounding the sector amid the troubles faced by Valeant (VRX) and others, but an analyst at Leerink contends in a note to investors that the pullbacks in both stocks provide buying opportunities. BACKGROUND: Drugmaker Valeant and its prior specialty pharmacy partner, Philidor Rx Services, have been at the center of the firestorm engulfing the sector. Following claims that Philidor urged its employees to modify prescriptions to ensure more orders of Valeant-branded drugs rather than generics, as well as other allegations of wrongdoing, Express Scripts (ESRX) and peer CVS Health (CVS) terminated Philidor from their networks. The day after those termination announcements, Valeant said that it was severing all ties with Philidor and that the pharmacy planned to shut down operations as soon as possible, consistent with applicable laws. Valeant has subsequently said that Philidor has committed to cease operations by January 30, 2016, at the latest. More recently, Express Scripts, the nation's largest pharmacy benefit manager, announced that it stopped doing business with Linden Care, accusing it of being a "captive" pharmacy that dispenses mostly products made by Horizon Pharma (HZNP). In turn, Horizon called the idea that Linden Care is a captive pharmacy "entirely false," stating that "at best Express Scripts is being reckless in its allegations and at worse it is intentionally attempting to mislead investors." Express Scripts' move also impacted shares of Insys Therapeutics (INSY), which reportedly also used Linden Care to fulfill prescription for its drugs. DIPLOMAT LIKELY TO STAY IN-NETWORK: Leerink analyst David Larsen acknowledged that recent events indicate that Express Scripts appears to be evaluating certain retail pharmacies and their relationships with manufacturers, but he believes Diplomat's mix of drugs for diseases like multiple sclerosis, HIV, hepatitis C and cancer differentiate it as a "true" specialty pharmacy. Larsen does not think Diplomat is at risk of being excluded from the pharmacy networks of Express Scripts, CVS or UnitedHealth's (UNH) Optum, he tells investors. Larsen expects limited distribution agreements to stay an important channel strategy for drugmakers and believes these agreements are appropriate for high cost specialty drugs that require special handling and additional services to manage patient adherence. The analyst, who thinks Diplomat remains well positioned to deliver annual growth of over 30% in the next several years, keeps an Outperform rating on its shares. EXPRESS BUYING OPPORTUNITY: Larsen also thinks concerns around manufacturer and pharmacy relationships have put unwarranted pressure on shares of Express Scripts. He does not expect Express Scripts to disclose new lawsuits around rebate dollars owed over other manufacturer disputes and keeps an Outperform rating on the stock, which he views as having an "attractive" valuation. WHAT'S NOTABLE: Larsen also thinks that the specialty channel remains an opportunity for Walgreens Boots Alliance (WBA) and believes its proposed acquisition of Rite Aid (RAD) can strengthen its specialty offering. The analyst keeps an Outperform rating on Walgreens shares as well. PRICE ACTION: Over the last three months, Diplomat Pharmacy shares have declined 28%, Express Scripts has fallen 6% and Walgreens has dropped 14%.
07:40 EDTICEBGC and GFI agree to sell Trayport to Intercontinental Exchange for $650M
BGC Partners (BGCP) and its majority-owned division, GFI Group (GFIG) announced that GFI has entered into an agreement to sell its Trayport business to Intercontinental Exchange (ICE) for $650M. Trayport is a provider of trading and aggregation software primarily in the global OTC energy and commodities markets. Trayport, which is domiciled in the UK, generated revenues of approximately $80M over the twelve months ended September 30, 2015. These revenues were predominantly generated via recurring software license and subscription fees. Trayport's revenues increased by approximately 9 percent year-on-year in British pounds during the third quarter of 2015. Under the terms of the purchase agreement, Intercontinental Exchange will acquire the equity of the companies that comprise the Trayport business. The GFI sellers will receive $650 million in ICE common shares based on the closing stock price on November 13, 2015. The aggregate number of ICE common shares is approximately 2.5 million, and up to approximately 0.8 million additional ICE common shares based on a sliding scale from $193.85 to $258.47 in the event that ICE's weighted average stock price over a specified period leading up to closing is less than $258.47. GFI will have the right to sell its ICE common shares pursuant to a registration rights agreement. ICE may elect to substitute cash for part or all of the stock consideration owed to the GFI sellers. The transaction is subject to certain closing conditions, including receipt of required regulatory approvals. The transaction is expected to close as early as the first quarter of 2016, subject to receipt of such approvals. After the close of the transaction, BGC and GFI are expected to remain customers of Trayport. The net tax the Company will pay with respect to the transaction is expected to be at a rate of 15 percent or less. The one-time gain will be reflected in BGC's consolidated results under U.S. generally accepted accounting principles, but will be excluded from the Company's results for distributable earnings.
07:32 EDTICEIntercontinental Exchange to buy Trayport from BGC, GFI for $650M
Intercontinental Exchange (ICE) announced that it has entered into a definitive agreement to acquire Trayport for $650M in ICE common stock. Trayport is a subsidiary of GFI Group (GFIG), which was acquired by BGC Partners (BGCP) in March 2015. Trayport licenses its technology platform to serve brokers for electronic and hybrid trade execution primarily in the European over-the-counter utility markets. The transaction will enable ICE to provide new services to the European OTC energy markets, including European power, natural gas and coal. The $650M purchase price will be paid with 100% equity consideration comprising approximately 2.5M shares of ICE common stock. ICE anticipates an immaterial impact to 2016 adjusted earnings per share. The agreement was unanimously approved by the Boards of Directors of both companies. The transaction is expected to close in the first quarter of 2016, subject to the completion of closing conditions and receipt of applicable regulatory approvals.
07:25 EDTKMXAuto retailers outlook still positive, says KeyBanc
After conducting extensive channel checks in October, KeyBanc believes that the sales outlook of the auto retailer sector remains strong. The firm is "becoming cautiously optimistic" on the outlook for the sector's new vehicle gross profit per unit. It keeps Outperform ratings on Asbury Automotive (ABG), Lithia Motors (LAD), Penske Automotive (PAG), CarMax (KMX), and Group 1 Automotive (GPI).
07:23 EDTORCLOracle upgraded to Conviction Buy from Buy at Goldman
Goldman added Oracle to the Conviction Buy List and increased its price target to $47 from $45 on shares following checks that indicate cloud revenue growth will accelerate in second half 2016. Analyst Heather Bellini said investors continue to have concerns about management's cloud guidance but field work provides increasing confidence Oracle will be successful in achieving 2016 bookings targets and expects management to guide towards accelerating revenue growth and gross margin expansion in 2017. Bellini sees 2016 as a bottom in non-GAAP operating margins and expects the Street's focus to shift towards cloud execution, leading to multiple expansion.
06:27 EDTGOOGYandex extends Google antitrust battle to EU, Bloomberg reports
Subscribe for More Information
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use